ProofPilot is made for Researchers at leading pharmaceutical companies. It is made for Entrepreneurs who created a potentially life-changing product and they aim to prove it works. It is made for Communities that want to help the less fortunate.
Most importantly, we made ProofPilot for patients. The platform was designed with the participant in mind, with an engaging experience for each person from the beginning of their health journey, to uncover potential solutions for their wellbeing.
Before launching ProofPilot, our founders worked at a consulting firm. Our focus was to help institutions develop different online HIV prevention strategies in the United States, targeting gay men. The studies were ahead of their time for being hosted on open-source software, but there were serious issues.
We were frustrated at the cost & time-intensive tasks it took to launch even one study (before ProofPilot, a study could take years to kick-off). The problems didn’t end there, though. We were unsettled at the time at how patients were treated in the study – they were an afterthought! More often than not, at the end of a clinical trial, they were completely forgotten and left in the dark.
If these institutions really wanted to find what works to improve personal and societal health, in a cost effective and timely way, something had to change. And that’s how ProofPilot was born. We initially created it to solve our own problems, and in the process of doing so, we created a solution that makes research affordable, accessible, engaging, and – dare we say it – fun.
CEO & founder Matthew Amsden took a leap of faith and founded ProofPilot, before clinical trials were typically done online
Prolific futurist and health investor Esther Dyson joins forces with ProofPilot, in effort to fast track health in the U.S. and world
In 2019, some epic studies launched in traditional health, wellness, and influencer worlds, such as Dr. Hyman, Eli Lilly, Elysium, and Take Care of
ProofPilot announces its series B investment from Mitsui.
Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot, most recently in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office. He brings a wide array of pharmaceutical research industry knowledge and utilizes a unique approach that integrates his experiences working for other Sponsors such as Shire and Merck, CROs, and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.
Savi Glowe has 15 years of experience in clinical research, data science, and executive leadership from top-tier academic medical institutions. As the Senior Director of Strategy & Operations in the Icahn School of Medicine at Mount Sinai, she led the organization, development, and execution of key research initiatives and directed operational efforts supporting digital health institutes and most recently data science response efforts during the first wave of COVID-19. Her work in clinical research supported studies in rare genetic diseases, lab and consumer device validation, skin disorders, Lyme Disease, and precision wellness. Prior to Mount Sinai, Savi managed clinical research operations for the Neuro-urology research group at Stanford University.
Michelle Rogers joins Proof Pilot with 20 years of industry experience that spans the clinical and real-world space. Her executive experience includes life science technology, and in her prior role, Michelle was the North American Real-World Evidence Regional Head, Data Generation for IQVIA. In this role, she was responsible for site managers and clinical research associates, and operational delivery success in the region. In addition to Michelle’s operational expertise, she has extensive experience in Business Development with a consistent history of exceeding company goals and driving organizational growth within the U.S., European, and Asian markets. Michelle holds a Bachelor of Science in Cellular and Molecular Biology from Chapman University.
Collaborative computer science engineer with over 15 years of global experience designing and deploying cutting-edge technologies in diverse industries. Holds a master’s degree in big data, data management and technological innovation. Hands-on leader who excels at coaching and mentoring both local and geographically dispersed teams. Works closely with internal and external stakeholders to translate business needs into technology services/products that solve complex issues and drive business growth.
Noam has been creating relationships and building collaborations across the healthcare ecosystem for over 20+ years — working with Pharma, Biotech and Medical Devices companies, as well as health systems and employers. He is recognized across the industry for his innate ability to understand clients goals and challenges and offer unique tech-enabled solutions. He has successfully introduced innovative digital health data research tools for both patients and clinicians to enable clients to optimize pre/post commercial market readiness and achieve measurable performance improvement. He brings to ProofPilot years of proven experience in business development, along with a relentless pursuit of making a positive impact on the healthcare industry. Noam loves life, and his favorite activities include singing in his band (playing guitar and sax, too) as well as skiing, hiking, and traveling with his wife and three ‘grown-ish’ children.